Literature DB >> 15193701

Soluble CD40 ligand and platelets: self-perpetuating pathogenic loop in thrombosis and inflammation?

Pal Aukrust, Jan Kristian Damas, Nils Olav Solum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15193701     DOI： 10.1016/j.jacc.2004.03.023

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  18 in total

1.  Developmental changes in soluble CD40 ligand.

Authors:  Jill M Cholette; Neil Blumberg; Richard P Phipps; Michael P McDermott; Kelly F Gettings; Norma B Lerner
Journal:  J Pediatr       Date:  2007-10-24       Impact factor: 4.406

2.  Circulating soluble CD40 ligand mediates the interaction between neutrophils and platelets in acute coronary syndrome.

Authors:  Budi Y Setianto; Anggoro B Hartopo; Putrika P R Gharini; Dyah W Anggrahini; Bambang Irawan
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

3.  miR-590-3p mediates the protective effect of curcumin on injured endothelial cells induced by angiotensin II.

Authors:  Tian Wu; Yuanyuan Xiang; Yu Lv; Dai Li; Lijin Yu; Ren Guo
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

4.  Inflammatory response to percutaneous coronary intervention in stable coronary artery disease.

Authors:  Peter S Munk; Unni M Breland; Pål Aukrust; Oyvind Skadberg; Thor Ueland; Alf I Larsen
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

5.  Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis.

Authors:  Jorge L Gamboa; Mias Pretorius; Deanna R Todd-Tzanetos; James M Luther; Chang Yu; T Alp Ikizler; Nancy J Brown
Journal:  J Am Soc Nephrol       Date:  2011-12-08       Impact factor: 10.121

6.  A Pilot Study on the Effect of Angiotensin Receptor Blockers on Platelet Aggregation in Hypertensive Patients- A Prospective Observational Study.

Authors:  Arun Suresh; Narendranath Sanji; Pallavi Mahadeva Kamath; Srinivas Lokikere Devendrappa; Shashikala Gowdara Hanumanthareddy; Imran Maniyar; Suresh Surappla Rudrappa
Journal:  J Clin Diagn Res       Date:  2016-11-01

7.  Does anti-TNF therapy cause any change in platelet activation in ankylosing spondylitis patients? A comparative study.

Authors:  Hüseyin Orüm; Gülsüm Emel Pamuk; Omer Nuri Pamuk; Muzaffer Demir; Burhan Turgut
Journal:  J Thromb Thrombolysis       Date:  2012-02       Impact factor: 2.300

8.  Biochemical markers for cardiovascular risk following treatment in endogenous Cushing's syndrome.

Authors:  C Kristo; T Ueland; K Godang; P Aukrust; J Bollerslev
Journal:  J Endocrinol Invest       Date:  2008-05       Impact factor: 4.256

9.  Nuclear factor of activated T cells (NFAT) mediates CD154 expression in megakaryocytes.

Authors:  Scott A Crist; Daniel L Sprague; Timothy L Ratliff
Journal:  Blood       Date:  2008-01-07       Impact factor: 22.113

10.  Systemic biomarkers of inflammation and haemostasis in patients with chronic necrotizing pulmonary aspergillosis.

Authors:  Ernst Kristian Rødland; Thor Ueland; Stine Bjørnsen; Ellen Lund Sagen; Christen Peder Dahl; Anne Naalsund; Tom Eirik Mollnes; Frank R Brosstad; Fredrik Müller; Pål Aukrust; Stig S Frøland
Journal:  BMC Infect Dis       Date:  2012-06-25       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.